Abatacept is a Promising Treatment for Patients with Disseminated Morphea Profunda: Presentation of Two Cases
DOI:
https://doi.org/10.2340/00015555-1136Keywords:
abatacept, morphea profunda, mRodnan skin score, Orencia.Abstract
Morphea profunda is a rare disease that mainly affects young women and often has a progressive course with physical and psychological sequelae. The skin becomes sclerotic after an initial inflammatory reaction and joint contractures can develop. The aetiology is unknown. Until now, no successful therapy has been proven for this morphea variant. On the basis of new insights into the key role of effector T cells in scleroderma, in particular Th-17, T-cell directed therapies are expected to have promising effects. We report here the first two cases of morphea profunda treated with abatacept. Abatacept had a clinical effect on the active disease, in addition to softening old sclerotic lesions.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 Birgitte Stausbøl-Grøn, Anne B. Olesen, Bent Deleuran, Mette S. Deleuran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
